In glaucoma suspects with IOP less than 22 mmHg and fewer than three risk factors, what is the typical follow-up approach?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

In glaucoma suspects with IOP less than 22 mmHg and fewer than three risk factors, what is the typical follow-up approach?

Explanation:
The main idea is that glaucoma suspects with low risk need careful surveillance rather than immediate treatment. When intraocular pressure is under 22 mmHg and there are fewer than three risk factors, the best approach is to follow up regularly, typically every 3 to 12 months, and look for any signs of progression. During these checks you monitor the IOP, examine the optic nerve head for changes in cupping or nerve damage, repeat imaging of the retinal nerve fiber layer (like OCT), and perform visual field testing as appropriate. If any progression or a rise in risk factors is detected, you would reconsider treatment. A follow-up interval of two years could miss early progression, and ignoring changes or starting therapy right away in this low-risk group isn’t necessary; the plan is to observe closely and intervene only if progression or increased risk appears.

The main idea is that glaucoma suspects with low risk need careful surveillance rather than immediate treatment. When intraocular pressure is under 22 mmHg and there are fewer than three risk factors, the best approach is to follow up regularly, typically every 3 to 12 months, and look for any signs of progression. During these checks you monitor the IOP, examine the optic nerve head for changes in cupping or nerve damage, repeat imaging of the retinal nerve fiber layer (like OCT), and perform visual field testing as appropriate. If any progression or a rise in risk factors is detected, you would reconsider treatment. A follow-up interval of two years could miss early progression, and ignoring changes or starting therapy right away in this low-risk group isn’t necessary; the plan is to observe closely and intervene only if progression or increased risk appears.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy